US Approves NVDA H200 Chip Sales to 10 Chinese Buyers; Stock Near $231
The U.S. government approved sales of NVIDIA's H200 chips to 10 Chinese companies, signaling a thaw in U.S.-China AI restrictions and spurring fresh momentum in $NVDA. Jensen Huang's Beijing visit alongside Trump and Xi reinforces the narrative that AI infrastructure demand transcends geopolitical tensions, lifting tech sector conviction.
RKey facts
- U.S. government approved NVDA H200 sales to 10 Chinese companies on May 14
- NVDA shares rose 20% in seven days, stock near $231, market cap nearing $6 trillion
- Jensen Huang attended state banquet with Trump, Xi, and other tech CEOs in Beijing
- Analysts cite strong AI capex demand transcending geopolitical tensions as primary driver
What's happening
The headline catalyst this week is the U.S. government's approval for NVIDIA to sell advanced H200 chips to a tranche of 10 Chinese companies. This marks a significant shift in the tone of U.S.-China technology negotiations, which have dominated headlines since the Iran conflict and supply-chain fragmentation fears took hold. NVIDIA CEO Jensen Huang was physically present at a state banquet in Beijing alongside President Trump and President Xi Jinping on May 14, an optics win that underscores the chipmaker's centrality to both economies' AI ambitions.
The market has parsed this as a green light for sustained AI capex flows, even amid geopolitical friction. NVDA shares rallied 20% over seven days, with the stock approaching $231 and the company nearing a $6 trillion market capitalization. Trading volumes spiked as retail and institutional buyers rushed to secure positions ahead of earnings and potential guidanceCompany-issued forecasts of future financial performance. upside. Huang's presence in Beijing, framed as part of a broader "business delegation" of CEOs that included Tim Cook (Apple), Elon Musk (Tesla), and others, reinforces the idea that Washington and Beijing recognize AI infrastructure as economically crucial enough to transcend the current conflict.
For the broader market, the narrative pivot is from "Will supply-chain wars kill the AI boom?" to "AI demand is too big to be killed by politics." This benefits semiconductor equipment makers (AVGO, ASML in Europe), AI software plays (PLTR), and amplifies conviction in mega-cap tech holdings. Energy importers and shipping stocks face headwinds from the ongoing Iran conflict and strait closures, but the AI narrative is strong enough to overwhelm near-term macro noise.
Critics note that a single approval does not reverse structural U.S.-China tech decoupling; moreover, the scale of Chinese chip purchases may remain capped by U.S. policy guardrails. Some bear-case voices argue that NVIDIA's valuation already reflects near-infinite growth, and any pause in expansion could trigger sharp mean reversion. Still, for now, the street is treating the H200 approval as validation that AI infrastructure spending remains both real and broadly geopolitically resilient.
What to watch next
- PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Matrix Service Company - MTRX
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Matrix Service Company ("Matrix" or the "Company") (NASDAQ: MTRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
16m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BayCom Corp - BCML
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BayCom Corp ("BayCom" or the "Company") (NASDAQ: BCML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forward Air Corporation - FWRD
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Forward Air Corporation ("Forward Air" or the "Company") (NASDAQ: FWRD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Replimune Group, Inc. ("Replimune" or the "Company") (NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veritone, Inc. - VERI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veritone, Inc. ("Veritone" or the "Company") (NASDAQ: VERI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sanara MedTech, Inc. ("Sanara" or the "Company") (NASDAQ: SMTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Angi Inc. - ANGI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Angi Inc. ("Angi" or the "Company") (NASDAQ: ANGI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns...
1h ago
Related coverage
- Trump Hosts State Banquet in Beijing With Musk, Huang, Cook; CEO Delegation Eyes China DealsEquities US··0 mentions
- Trump-Xi Summit: Musk, Huang, Cook Dinner Signals Tech-China Deal MomentumTech & AI··0 mentions
- S&P 500, Nasdaq Hit Fresh Records on AI Momentum and Retail DataEquities US··0 mentions
- NVDA H200 Chips Approved for 10 Chinese Companies as Trump-Xi Summit Signals Trade ThawTech & AI··0 mentions
More about $NVDA
- Top 10 US Stocks Now Drive Record Share of SPY Gains; Breadth Concerns Mount·Equities US
- Cerebras IPO Raises $5.55B, Shares Indicated Up 89% on AI Chip Appetite·Tech & AI
- US Approves $NVDA H200 Chip Sales to China; Beijing Trip Sparks Demand Optimism·Tech & AI
- S&P 500, Nasdaq Hit Records on AI Rally; Only 1 in 4 Active Managers Beating Market·Equities US
- Cerebras IPO Surges 89% on Listing; AI Chipmaker Raises $5.55 Billion·Tech & AI
Top 10 names now over 38% of the S&P 500. What that means for SPY holders, passive flows and tail risk.